30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Freeman Chris

Insider profile

Performance

Overall performance
2.7

Performance over holding periods
2.7
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 86% 68% 82%
Transactions
11 0% Buy
34 71% Buy
47 69% Buy
Freeman Chris's trades of Guardant Health Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-26 2026-05-22 S Sale
72,710 +27.0%
404.75
US$4,700,002
72,710 +27.0% 404.75 US$4,700,002
2026-05-22 2026-05-22 PrS Proposed sale
51,409
226.95
US$1,398,352
51,409 226.95 US$1,398,352
2025-12-08 2025-12-05 S Sale
51,676 -27.3%
136.54
US$501,901
51,676 -27.3% 136.54 US$501,901
2025-12-08 2025-12-05 S Sale
400 -1.4%
105.99
US$42,395
400 -1.4% 105.99 US$42,395
2025-12-08 2025-12-05 S Sale
6,555 -18.3%
103.97
US$681,534
6,555 -18.3% 103.97 US$681,534
2025-12-08 2025-12-05 S Sale
3,414 -8.7%
103.25
US$352,505
3,414 -8.7% 103.25 US$352,505
2025-12-08 2025-12-05 S Sale
11,969 -23.3%
102.09
US$1,221,970
11,969 -23.3% 102.09 US$1,221,970
2025-12-08 2025-12-05 S Sale
4,084 -7.4%
101.40
US$414,129
4,084 -7.4% 101.40 US$414,129
2025-12-08 2025-12-05 S Sale
228 -0.4%
106.63
US$24,312
228 -0.4% 106.63 US$24,312
2025-12-08 2025-12-05 S Sale
244 -0.4%
104.10
US$25,400
244 -0.4% 104.10 US$25,400
2025-12-08 2025-12-05 S Sale
372 -0.7%
103.48
US$38,495
372 -0.7% 103.48 US$38,495
2025-12-08 2025-12-05 S Sale
744 -1.3%
102.31
US$76,116
744 -1.3% 102.31 US$76,116
2025-12-08 2025-12-05 S Sale
478 -0.8%
101.43
US$48,482
478 -0.8% 101.43 US$48,482
2025-12-05 2025-12-05 PrS Proposed sale
31,452
103.07
US$3,241,621
31,452 103.07 US$3,241,621